Blood Transcriptome Profiling Highlights the Role of Intestinal Bacterial Translocation in Severe COVID-19

Area of Science:

• Immunology
• Genomics
• Infectious Diseases

Background:

• COVID-19 has caused millions of deaths globally, underscoring the need to understand severe disease mechanisms.
• Characterizing molecular biomarkers is crucial for identifying severe COVID-19 cases and developing targeted therapies.

Purpose of the Study:

• To investigate transcriptional differences in whole blood gene expression between mild and severe COVID-19 patients.
• To identify differentially expressed genes and enriched pathways associated with severe COVID-19.
• To analyze immune cell population dynamics in relation to disease severity.

Main Methods:

• Whole blood gene expression profiling using Next Generation Sequencing.
• Gene Ontology (GO) enrichment analysis of differentially expressed genes.
• Digital cytometry to estimate immune cell abundance (22 types).

Main Results:

• Enriched GO terms indicated a response to bacterial molecules like lipopolysaccharide (LPS), suggesting intestinal bacterial translocation.
• Severe COVID-19 patients showed increased neutrophils and depleted monocytes, CD8+ T cells, and activated Natural Killer (NK) cells.
• Distinct immune cell population dynamics correlated with severe disease and bacterial translocation.

Conclusions:

• Intestinal bacterial translocation is highlighted as a potential driver of severe COVID-19.
• The study elucidates the molecular basis and immune cell dysregulation underlying severe COVID-19.
• Findings provide insights into biomarkers and mechanisms of severe disease progression.